Filing Details

Accession Number:
0001140361-17-037087
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-02 15:04:37
Reporting Period:
2017-09-29
Accepted Time:
2017-10-02 15:04:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
868278 Prophase Labs Inc. PRPH Pharmaceutical Preparations (2834) 232577138
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1373603 Michael Braden Leonard 65 E Cedar - Suite 2
Zionsville IN 46077
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-09-29 1,695,305 $2.30 627,322 No 4 S Indirect Holding of BML Investment Partners, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Holding of BML Investment Partners, L.P.
Footnotes
  1. 1. These shares were sold to the Issuer through the tender offer by the Issuer for 4,000,000 shares of its common stock.
  2. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.